Loading
N-Power Medicine, Inc.
N-Power Medicine, Inc. is a biotechnology research company founded in 2021, based in Redwood City, California. The company operates the first always-on clinical research system in community oncology, which enhances drug development by allowing cancer patients to participate in research as trial participants or through its Prospective External Control Arm (ProECA). N-Power Medicine offers a comprehensive data collection and clinical trial platform that integrates technology with trained personnel. Key products include the Kaleido Registry, a real-time patient-consented registry for standardized data collection, and the ProECA Platform, which streamlines clinical trials and reduces development timelines. The company collaborates with biopharma partners like Merck and AdventHealth, and supports community oncology practices by connecting them with research opportunities. With a mission to accelerate oncology research and development, N-Power Medicine is committed to delivering life-saving therapies more efficiently.
Funding
Every round, secondary, debt facility or acquisition involving N-Power Medicine, Inc. that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$20M